[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-CRSP":3,"homepage-market-summary":31,"stock-news-CRSP":172},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"CRSP","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"CRISPR Therapeutics AG","Nasdaq",null,"BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)","Crispr Therapeutics is a gene editing company focused on the development of Crispr\u002FCas9-based therapeutics. Crispr\u002FCas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)\u002FCrispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.","393","Zug",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},55.43,56.45,57.58,54.09,55.44,-0.01,-0.02,1125624.504817,20207,55.2505,78.48,44.12,1866722.8931763,32.9,2502,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":154},"success",[34,42,49,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":40,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":14,"sparkline":76,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":40,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":40,"sparkline":91,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":40,"sparkline":98,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[100,105,110,114,119,124,129,134,139,144,149],{"name":101,"etf":102,"change":103,"price":104,"is_up":40},"Technology","XLK",1.01,199.81,{"name":106,"etf":107,"change":108,"price":109,"is_up":40},"Financials","XLF",0.06,53.49,{"name":111,"etf":112,"change":21,"price":113,"is_up":14},"Healthcare","XLV",166.18,{"name":115,"etf":116,"change":117,"price":118,"is_up":40},"Consumer Cycl","XLY",1.13,110.04,{"name":120,"etf":121,"change":122,"price":123,"is_up":40},"Consumer Staples","XLP",0.25,80.53,{"name":125,"etf":126,"change":127,"price":128,"is_up":40},"Energy","XLE",0.4,62.95,{"name":130,"etf":131,"change":132,"price":133,"is_up":40},"Industrials","XLI",0.78,169.95,{"name":135,"etf":136,"change":137,"price":138,"is_up":40},"Materials","XLB",0.66,48.86,{"name":140,"etf":141,"change":142,"price":143,"is_up":40},"Real Estate","XLRE",0.32,40.81,{"name":145,"etf":146,"change":147,"price":148,"is_up":40},"Utilities","XLU",0.38,39.83,{"name":150,"etf":151,"change":152,"price":153,"is_up":40},"Comm Services","XLC",0.35,110.32,[155,160,164,168],{"ticker":156,"name":157,"price":158,"change":159,"is_up":40},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":161,"name":162,"price":163,"change":90,"is_up":40},"QQQ","Invesco QQQ Trust",749.58,{"ticker":165,"name":166,"price":167,"change":54,"is_up":40},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":169,"name":170,"price":171,"change":68,"is_up":40},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":173,"articles":174},20,[175,181,187,193,198,204,210,216,222,227,232,236,241,246,251,255,260,265,269,274],{"title":176,"link":177,"pubDate":178,"description":179,"source":180},"CRISPR Therapeutics (Nasdaq:CRSP) - Stock Analysis - simplywall.st","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikAFBVV95cUxQU1dZQ3F4MVN3Zk5LUVJFclUtYWIxOE5ZYmE5TzZaYW0ya2JUS3VlLXVBQ291N0ctV3JJMWhiWFlVVWRVZzZPUkNiLXp0dFppNUtCeDhmdHp5bkpjVEQtWV9EdjdtMTdhZnhtN3VrQ3dsdDJkeTNlRF9aX29Vc2ZtaWRHdm03TzV3QlhQc0cwZXY?oc=5","Mon, 21 Sep 2026 07:00:00 GMT","CRISPR Therapeutics (Nasdaq:CRSP) - Stock Analysis simplywall.st","simplywall.st",{"title":182,"link":183,"pubDate":184,"description":185,"source":186},"CRISPR Therapeutics AG (CRSP) Stock Moves 1.20%: What You Should Know - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMinwFBVV95cUxPdXpockVFX0U2Y0ZvNjhrLW1nRkVYTEtzRENiWTlxTEF1MnNzQWZaRFRlRkQ2OFhJcEZYQXVqSkVTN01mUmt1dEh0Q1Fza1R1bXR0X2d1MjduYU11bnNPSVl5dGR5TXAwQjZoN0FqMlAtRmtieHNkYUg5QU9sdmZoeU1QaHVUV2RJNFVtSjljVUZtbkQ1TkplSXljakZjeWc?oc=5","Tue, 22 Sep 2026 07:00:00 GMT","CRISPR Therapeutics AG (CRSP) Stock Moves 1.20%: What You Should Know Yahoo Finance","Yahoo Finance",{"title":188,"link":189,"pubDate":190,"description":191,"source":192},"Anthropic Just Made a CRISPR-Like Discovery. What It Actually Means for CRSP Stock Investors. - Barchart.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0AFBVV95cUxQem5feVNJUHFjMHlYVElaSGlmTkkxZFktYXhDTHpRRUtmNzVKRWpPZTM5M3NFZF9rallVd1p2NktlQWdmUjRSSzhXRnRLT1FKOGljcjdyUEJDV0VSbF9URmRKd3FoSllac25TVDFUTnVONjVXczFiczN4Tm9FYjZPVFJlNDRXR1N6MkMyaWtPRHFRQnBXR05IS0I5d0pyUFFXdUJpVHBaZEhfd3JhSk1obk1TTDgtTWhZVm45Q3RzU0k5aTR6V3daek5DblVEYm5N?oc=5","Wed, 30 Sep 2026 14:07:40 GMT","Anthropic Just Made a CRISPR-Like Discovery. What It Actually Means for CRSP Stock Investors. Barchart.com","Barchart.com",{"title":194,"link":195,"pubDate":178,"description":196,"source":197},"Ali Behbahani Sells 13,679 Shares of CRISPR Therapeutics (NASDAQ:CRSP) Stock - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0AFBVV95cUxOWWlEUVdiZTN2dEVjbjU0MElfQk9GdE9jS3UyU28zeGNiVDVSWXJhek5VNU5FaDIxT3JhcnlONEJ5dUFpREhoVjl5TXNvNW5VZkREeERKYzFNUEdrbFlLb291NXNiNFFNQ0VUdjYzSGtwSTY4ZkotMExiNHVUbmNUNG1NYUJUc2VpaGNvbHlFejY0aEQxQXFCZmRwd2cwSU1sYkxHSTZRWkVuM2tsdkZneTVBYlJOb0huTnc0dzlGbXpQY2NxNVpERVpwLUNQVlFo?oc=5","Ali Behbahani Sells 13,679 Shares of CRISPR Therapeutics (NASDAQ:CRSP) Stock MarketBeat","MarketBeat",{"title":199,"link":200,"pubDate":201,"description":202,"source":203},"CRISPR Therapeutics AG (CRSP) stock price, news, quote and history - Yahoo Finance Australia","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiUkFVX3lxTFBoQXpFRks2eXE3Vk9MSkZrZks1SmFpOTcxbVo3MEI3SG45bGQ4QzVxRTRwU2RqUl9QMEV5MXJPRnVCLUhHYk15WE1WYl9lRDc0aUE?oc=5","Sat, 03 Oct 2026 04:04:41 GMT","CRISPR Therapeutics AG (CRSP) stock price, news, quote and history Yahoo Finance Australia","Yahoo Finance Australia",{"title":205,"link":206,"pubDate":207,"description":208,"source":209},"An experimental scleroderma treatment uses immune cells with changed genes. Early data will be presented Nov. 8. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitwFBVV95cUxNT2REN2NtVVBmZ290Tl94TzZPQkJUeVBPbVVjd1ZybTNYZ0dLdk82WnZDTGpuc0pWejE3dDFZaWFaTy0wY2o0WWtzR1ptWGhnNUhwOWpKVVBaSDlLRzFONmxTLXRaWVNrUHkzX2FJeUUyTGFPUWtBN3FzRGVUTndFampWejRIQlNQUy0xdGNLNFNVV0RwZXN4VWFWUjR3MmlEZjRNTzczU2dGRXhNUW92RXZQTXdHMzg?oc=5","Fri, 02 Oct 2026 17:12:35 GMT","An experimental scleroderma treatment uses immune cells with changed genes. Early data will be presented Nov. 8. Stock Titan","Stock Titan",{"title":211,"link":212,"pubDate":213,"description":214,"source":215},"Gene editing stocks fall after Anthropic’s CRISPR-like discovery - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimgFBVV95cUxOY1lTUGRabXF1anFYVnFxUXpGOHdlNUlGNHltSEtBWVRqa2dTMW85Z05FZ0xhdzJ3bXdQQV9FRERZYnJFX0VtYVFBTnhQemtLYklYQk1GTG9PcHpBMExuYmkySlhMNmFhNzVzZXBWbWFweDlqN2JFamVzTjVuemR2U1RpNGN1RHJXaVZDNHl4RVFocklaR0ZuN1N3?oc=5","Wed, 23 Sep 2026 07:00:00 GMT","Gene editing stocks fall after Anthropic’s CRISPR-like discovery Seeking Alpha","Seeking Alpha",{"title":217,"link":218,"pubDate":219,"description":220,"source":221},"CRSP 260925 54.00C (CRSP260925C54000) Stock Options Chain | Quotes & News - Moomoo","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiX0FVX3lxTFBQZV94WTVUd2daUzFYU0R4TmU3RERSaTZlZ0VpSzdLN2syZ0N2WVNaRVh1cG5CX0RrRk1sQWlkM0JfdEhyMkpydUVnWENBMV80VHl0bVQzbDhZM0ROVld3?oc=5","Sun, 27 Sep 2026 21:10:49 GMT","CRSP 260925 54.00C (CRSP260925C54000) Stock Options Chain | Quotes & News Moomoo","Moomoo",{"title":223,"link":224,"pubDate":225,"description":226,"source":180},"CRISPR Therapeutics (CRSP) Stock May Command A Premium On Its Equity Base - simplywall.st","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Fri, 02 Oct 2026 01:31:36 GMT","CRISPR Therapeutics (CRSP) Stock May Command A Premium On Its Equity Base simplywall.st",{"title":228,"link":229,"pubDate":230,"description":231,"source":186},"CRISPR Therapeutics (CRSP) Stock Looks Fully Valued As Book Value Questions Linger - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMingFBVV95cUxPRWVUeV93Wkx6cGF4OWF5eFRwSzkxQTRJd1pwb3hyZFFWdHZrWllmVmcySEdyWEdzZmljLThLNm9lRnlkd21oTEdsNklJdlBPNjBEdWNNeG9oME9qMUlLeDgyZmFOUFAwYmVSS1ctN3VqYXRFSmg2LU8yMk0waWxJNXRiMkJWSF9tRnhISDFLM1dKcVJ4UTUtQjN6NzVTdw?oc=5","Thu, 24 Sep 2026 07:00:00 GMT","CRISPR Therapeutics (CRSP) Stock Looks Fully Valued As Book Value Questions Linger Yahoo Finance",{"title":233,"link":234,"pubDate":178,"description":235,"source":209},"CRISPR Therapeutics (CRSP) director exercises options, then sells 13,679 shares around $57 - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitwFBVV95cUxNb2x2VUdZNTBEZTktQ0RORS16UTM5RkhJVUFNdEFCUEVjVXV3N1Y3dWFaZE9scFNFUElGY1k4V1hwV2U5UnNEVHBnZFRaTWtCWGVwNkJsV0Rkdno4V25RXzZDTDF3WlhTVEFoRG16dGNJWnNEZk1GbHA5SXBGQ2Jfallma2pZLVI0UnV5N0w5Sk5QU2E1Y1J2VmN2OXJzMzNmSVRKS1o0UGxWd0R5VFN4ODZJN0dwdlk?oc=5","CRISPR Therapeutics (CRSP) director exercises options, then sells 13,679 shares around $57 Stock Titan",{"title":237,"link":238,"pubDate":239,"description":240,"source":180},"CRISPR Therapeutics (CRSP) Stock May Trade At A Premium To Book Value - simplywall.st","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Thu, 24 Sep 2026 11:05:57 GMT","CRISPR Therapeutics (CRSP) Stock May Trade At A Premium To Book Value simplywall.st",{"title":242,"link":243,"pubDate":244,"description":245,"source":186},"CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMinwFBVV95cUxOVFJKSk5jMDdRdHBZX0I2OW5UT2VPMnRTYm42OW83dG10MnNDTFN0NjhWSEdnaGJuMEN2eWFDRFM0UkRoWEtjclo5RFN3d19nd0RKQnI4T0FKMHZYTXpZUXR3cWlxaTJGQ3Npb0Z0S1ktOWF1cUxRenlWbVVad3c0WVVOd0YybnNGZkRjeWNDSDJyWFRZcFhBNTQyVnBSdm8?oc=5","Fri, 25 Sep 2026 07:00:00 GMT","CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why Yahoo Finance",{"title":247,"link":248,"pubDate":249,"description":250,"source":209},"CRISPR Therapeutics (CRSP) counsel exercised options and sold 10,400 shares under a trading plan. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitwFBVV95cUxPRVRYUk5SMlJQdjA3dkhVX1JVdmNOLUU5Znl3MjdaekYzRnlKYmtGV1QtR0ViWXdQV0RCNWp2bWoyQUZlZnQtZTBpOGpHSlctZnY4ZHRnYk9DS2lzMFQ5MmlRSnZZQy11TzJNdWswRFp1YzdndG80Y2s1Mzdwa1BhSVpaR2hDT1JMWF9OWWUwZVR0cUxxLVk4X2k2ZE5acUhpNkU1dXVvY01SOE1PTnBLNFRKbFVwZjg?oc=5","Thu, 24 Sep 2026 21:36:25 GMT","CRISPR Therapeutics (CRSP) counsel exercised options and sold 10,400 shares under a trading plan. Stock Titan",{"title":252,"link":253,"pubDate":178,"description":254,"source":209},"Director at CRISPR Therapeutics (CRSP) gets stock in no-cash fund distribution - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitwFBVV95cUxNODR1VkpZa05EcHpHc3NDMjRNYVpPU01ma0FadzFMM24tYW9Md1NycU5CNVVwQU1lOFRndGVwSUpkbVkzdHJUN2pZd21kaFRkLThBWExTWkR4X01RUGFJOXk4UlktUzBxZmxpR0N6MHI2T1NuN2xZTkhueFkyNlRQMTZkSjNUVUFLQTgwV1VNbDIwZ0dDa2FsZ1hKMFoyWHlpS09DUXZ5TUlJV1NFNGRnYlNwcVQxMDQ?oc=5","Director at CRISPR Therapeutics (CRSP) gets stock in no-cash fund distribution Stock Titan",{"title":256,"link":257,"pubDate":258,"description":259,"source":209},"Insider plans $626K CRISPR Therapeutics (NASDAQ: CRSP) stock sale - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMioAFBVV95cUxQY0hiMjNDQmlacDVDQ2xuaEIxckJEd21oMm5Rem50cXZMTDlJalNyamNOZzVRM0VCUS1UZ1AtT2V0Nk1BeFRsbE9wRW5hWHRqcmctQklsODk3RERUWFI3M3ViSk9WYWt5UXZGRHlyaGh1ZWRnZ0c2bzZyUDFSelhtY0VqTzFxWmNwMk1HX2R3eEdBU1Q1SG9vVzh1ajJWbE92?oc=5","Tue, 22 Sep 2026 20:43:17 GMT","Insider plans $626K CRISPR Therapeutics (NASDAQ: CRSP) stock sale Stock Titan",{"title":261,"link":262,"pubDate":263,"description":264,"source":186},"CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipgFBVV95cUxPdG13blg5eU5YbWFOMW16cWh3YzZRMlVqUjdfRFE5bFg5RHpoeDNrTzEwemR5U3UtNUJCS0R6M1lNVkZpNHVybF9uSTJoSndTNDNHQmZXNVJCYTRyWGViRjFocnBCb2ZBdU1rVzJBM01OZk1ZYlBZOHhpdldVMmcyeFBuclVZYmNqd2ZRbWFQa3I1QmR5TzItS1dCblAxeU84SDB3OGFB?oc=5","Tue, 29 Sep 2026 12:00:01 GMT","CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know Yahoo Finance",{"title":266,"link":267,"pubDate":213,"description":268,"source":186},"CRISPR Therapeutics Traded Sideways and Down for 12 Months: One Wall Street Pro Expects 85% Gains Soon - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiowFBVV95cUxNSktabHNLZ0NLQmVIM3RhS09HczNKRldDZVFyZ3hxUk1OcUhDb0ZuMDJWajFNMGNNZ2Z4TDR4SWVmSnB2MlJIWmpSeGY0cG5ocGUzYlJQdnh2QmFjeENsWkVIdzY5Q0VFSTNDRHJjbnVFZWVFeHViRmVVV1d0d2FveTRJZzJHcktVMDF6WmtmTG9RLXBMUDlydzltYzdwUFZSakY4?oc=5","CRISPR Therapeutics Traded Sideways and Down for 12 Months: One Wall Street Pro Expects 85% Gains Soon Yahoo Finance",{"title":270,"link":271,"pubDate":213,"description":272,"source":273},"CRISPR Therapeutics Traded Sideways and Down for 12 Months: One Wall Street Pro Expects 85% Gains Soon - 24\u002F7 Wall St.","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi3AFBVV95cUxQWk1nY01FMHZGVWV2SUhISHJmNDdNd0o2R2FPUFFCcWdBY2VTMXUwcEFnRWFjQnk4Y0EydVJjZm9yN2NnbmVaNnNXVjFiMVRzV1RtVFNwaFpmTFJBODU3cXpqc3pzWVFsZDl3MmFmaDd0VUZmQ21BeUhjZkptaG1IYTZVOHMwMWU1RDV1blJLT2FRMUQzZ2tISWVpcEhiQVZtT3hVSVlDN29LRzI4SVNXeThZUno1VVIwQ0xqSVpoc0lzcmZFc05GR2dBYmw0bHJzQThNV1liZk9FQVdj?oc=5","CRISPR Therapeutics Traded Sideways and Down for 12 Months: One Wall Street Pro Expects 85% Gains Soon 24\u002F7 Wall St.","24\u002F7 Wall St.",{"title":275,"link":276,"pubDate":230,"description":277,"source":197},"CRISPR Therapeutics (NASDAQ:CRSP) General Counsel James Kasinger Sells 10,400 Shares of Company Stock - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi8gFBVV95cUxQYWJSWFVobDhWc0R1UnBsWFo2emplR3Q4RTM0SzVZTEx5R0IwM28zcEtidU1ZS3hEaFFUUmZsSWxGYTVCcWxrOXdZazlwcDNIdkdtQlBGLXViaVhtNGpublRKeTRMQmNMOVEwc2ZJMGZacFJoSzhQcWFCc0k3c2dtc3hCa251Z1NxeU1xM21SMnNYQzJqYjFQNkQ1NXJOYmlOZFpiY2FjWG5Gc2NLaDF2R3Q5U0I4NWJZTkFDSWxRV1ktQUJaZkFGZHMyeC1qeTVyU1pjNEFiTG9wcVZoZnR6dVlvRmthaFdRMHVxOVlrNGhWZw?oc=5","CRISPR Therapeutics (NASDAQ:CRSP) General Counsel James Kasinger Sells 10,400 Shares of Company Stock MarketBeat"]